J. Carey

Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.

Xian Chen, Jing Wang, K. Hunt, 2018, Cancer research.

Inhibitor of DNA binding 4: a novel tumor suppressor gene in prostate cancer

J. P. Carey, J. Carey, 2012 .

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

Xian Chen, K. Hunt, A. Sahin, 2021, Cancers.

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

O. Galm, J. Chaudhary, A. Asirvatham, 2009, BMC Cancer.

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer

Xian Chen, I. Ellis, K. Hunt, 2017, Oncotarget.

PKC iota promotes ovarian tumor progression through deregulation of cyclin E

G. Mills, K. Hunt, K. Keyomarsi, 2015, Oncogene.

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

Xian Chen, Jing Wang, K. Hunt, 2019, Clinical Cancer Research.